Article
A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinoma
Journal of Immunotherapy
(1996)
Disciplines
Publication Date
January 9, 1996
DOI
10.1097/00002371-199609000-00006
Citation Information
Robert G. Fenton, Ronald G. Steis, Karen Madara, Arnold H. Zea, et al.. "A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinoma" Journal of Immunotherapy Vol. 19 Iss. 5 (1996) p. 364 - 374 Available at: http://works.bepress.com/walter-urba/246/